Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | KOPRAN Kopran Limited Pharma · Small | WANBURY Wanbury Limited Pharma · Small | ANUHPHR Anuh Pharma Limited Pharma · Small | AHCL Anlon Healthcare Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 26 | 60 | 50 | 55 |
| Verdict | OVERVALUED | UNDERVALUED | FAIR VALUE | FAIR VALUE |
| Style | OVERVALUED | Growth at Value | FAIR_VALUE | FAIR_VALUE |
| Piotroski | 7/9 | 6/9 | 6/9 | 6/9 |
| Valuation | 4/30 | 12/30 | 16/30 | 10/30 |
| Growth | 3/25 | 21/25 | 12/25 | 21/25 |
| Quality | 0/20 | 20/20 | 2/20 | 11/20 |
| Balance Sheet | 10/15 | 0/15 | 12/15 | 10/15 |
| Cash Flow | 4/10 | 4/10 | 4/10 | 0/10 |
| Price | ₹183.25 | ₹265.75 | ₹77.55 | ₹15.14 |
| P/E | 34.20 | 20.50 | 18.50 | 26.20 |
| P/B | 1.65 | 13.92 | 2.16 | 3.26 |
| ROE | 4.91% | 76.50% | 12.10% | 18.40% |
| ROCE | 6.65% | 36.70% | 15.90% | 20.80% |
| Debt / Equity | 0.29 | 3.03 | 0.00 | 0.19 |
| FCF Yield | 0.23% | — | 1.98% | — |
| Dividend Y | 1.65% | — | 1.98% | — |
| Altman Z | 3.32 | 3.85 | 4.96 | 4.88 |
| Promoter % | 44.43% | 43.01% | 71.79% | 52.68% |
| Mkt Cap (₹Cr) | 879.00 | 882.00 | 759.00 | 747.00 |
| Graham # | ₹114.86 | ₹73.04 | ₹56.9 | ₹7.25 |
| Fair PE | 2.9 | 42.0 | 42.0 | 42.0 |
| MoS % | -1069.4% | +51.7% | +55.0% | +33.2% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startKOPRAN60
WANBURY102
ANUHPHR35
AHCL16